Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications drug utilization physician survey intron ® europe
Jing She Surveys and Observational Studies Parsippany, New Jersey, USA MPH, Public Health Boston University, Boston, MA BA Wuhan University, Wuhan, China Jing She, MPH, is an Associate Director of Data Management in the Surveys and Observational Studies …
… plan. The ultimate success of JCAs and market access in Europe will increasingly hinge on including key …
… of care delivered by internists compared with their physician and nonphysician counterparts, building risk …
… and quantify these treatment effects for the citizens of Europe.” The SIGMA Consortium’s VISION is to provide best … Toscana) Dr. Rosa Gini Netherlands PHARMO Institute for Drug Outcomes Research Prof. Ron Herings, FISPE Netherlands …
… FDA Guidance In June 2018, the United States Food and Drug Administration (US FDA) released an important guidance … the product or new use Product pricing information Patient utilization projections (e.g., epidemiological data … from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; …
… Sentinel Initiative, launched in 2007 by the US Food and Drug Administration (FDA), is a national electronic data …
… of RTI-HS. Ms. Zografos has a strong background in survey research, both in the public and private sector. She … with primary data collection in the United States and Europe. Ms. Zografos has experience with all aspects of data …
Investigating the Relationship Between Suboptimal Meningococcal Immunization and Health Disparities in the US Share on: April 5, 2023 Image Meningococcal disease is caused by the bacterium Neisseria meningitidis and can have serious, life-threatening …
… appropriate, our team will design and conduct an iterative survey and qualitative inquiry exercise with carefully vetted …
… outcomes (PROs) and are a major focus of ongoing drug development. The US Food and Drug Administration (FDA) strongly encourages the use of PROs …